Institution statistics

DANISH CANCER SOCIETY - Denmark 

Ranking results:

Past rankings:
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:69
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:700-800
Total Project Funding:600-700
Total Project Funding per Partner:500-600
Total Number of Projects:600-700
Networking Rank (Reputation):900-1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:500-600
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:600-700
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding:700-800
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:700-800
Total Project Funding:500-600
Total Project Funding per Partner:600-700
Total Number of Projects:500-600
Networking Rank (Reputation):600-700
Partner Constancy:400-500
Project Leadership Index:800-900
Diversity Index:500-600
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Partner Constancy:600-700
Project Leadership Index:600-700
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2017-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 43
As coordinator: 1
As participant: 39
Sole participant: 3
Coordinator / Participant Ratio: 0.03*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2016 0 3.990.269 399.027 1
2014 0 6.105.317 2.860.496 2
2013 0 11.989.807 874.186 2
2012 238.069 1.334.890 905.514 1 1
2011 0 21.496.758 1.752.907 4
2010 0 16.929.918 1.118.366 2
2009 0 13.714.909 865.513 2
2008 0 23.133.651 1.201.321 5
2006 0 36.190.602 974.255 3
2005 0 31.003.573 1.454.817 5
2004 0 17.430.273 959.454 3
2003 109.625 0 109.625 1
2002 90.000 1.992.965 278.479 1 2
2001 0 6.255.706 894.604 4
2000 143.802 6.368.946 722.068 1 3
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
KAROLINSKA INSTITUTE15
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER13
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE8
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE7
DEUTSCHES KREBSFORSCHUNGSZENTRUM6
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM6
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE6
MEDICAL RESEARCH COUNCIL6
CANCER RESEARCH UK5
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III5
INSTITUT CURIE5
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD5
THE UNIVERSITY OF TUEBINGEN5
INSTITUT CATALA D'ONCOLOGIA4
INSTITUT GUSTAVE ROUSSY4
LUND UNIVERSITY4
UNIVERSITY OF HELSINKI4
ACADEMISCH ZIEKENHUIS LEIDEN3
CENTRO PER LO STUDIO E LA PREVENZIONE ONCOLOGICA3
DEUTSCHES INSTITUT FUER ERNAEHRUNGSFORSCHUNG3
FUNDACIO CENTRE DE RECERCA EN EPIDEMIOLOGIA AMBIENTAL CREAL3
FUNDACION VASCA DE INNOVACION E INVESTIGACION SANITARIAS3
INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL3
ISTITUTO EUROPEO DI ONCOLOGIA3
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI3
ISTITUTO SUPERIORE DI SANITA3
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU3
ROYAL COLLEGE OF SURGEONS IN IRELAND3
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS3
THE NETHERLANDS CANCER INSTITUTE3
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II3
UNIVERSITY COLLEGE LONDON3
UNIVERSITY OF COPENHAGEN3
UNIVERSITY OF LEEDS3
WEIZMANN INSTITUTE OF SCIENCE3
AMYNON BIOTECH2
ANDALUSIAN SCHOOL OF PUBLIC HEALTH2
AUSTRIAN ACADEMY OF SCIENCES2
CENTRE HOSPITALIER UNIVERSITAIRE DE REIMS2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
CONSEJERIA DE SALUD Y SERVICIOS SANITARIOS DEL PRINCIPADO DE ASTURIAS2
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG2
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON2
FINNISH CANCER REGISTRY2
FORSCHUNGSZENTRUM KARLSRUHE2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
HELLENIC HEALTH FOUNDATION2
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE2
INSTITUT SCIENTIFIQUE DE SANTE PUBLIQUE2
INSTITUTO DE SALUD PUBLICA DE NAVARRA2
JOHANNES GUTENBERG UNIVERSITAET MAINZ2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
NORWEGIAN RADIATION PROTECTION AUTHORITY2
OSLO UNIVERSITETSSYKEHUS HF2
REGINA ELENA CANCER INSTITUTE2
RUPRECHT KARLS UNIVERSITAET HEIDELBERG2
RUSSIAN ACADEMY OF SCIENCES2
SATEILYTURVAKESKUS RADIATION AND NUCLEAR SAFETY AUTHORITY2
STICHTING VUVUMC2
TERVEYDEN JA HYVINVOINNIN LAITOS2
THE NETHERLANDS CANCER INSTITUTE / ANTONI VAN LEEUWENHOEK HOSPITAL2
THE UNIVERSITY OF MANCHESTER2
UMEA UNIVERSITET2
UNIVERSIDAD DE CORDOBA2
UNIVERSITAET BASEL2
UNIVERSITAET ULM2
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ2
UNIVERSITE CLAUDE BERNARD LYON 12
UNIVERSITE DE GENEVE2
UNIVERSITY MEDICAL CENTER UTRECHT2
UNIVERSITY OF AARHUS2
UNIVERSITY OF BOLOGNA2
UNIVERSITY OF CRETE2
UNIVERSITY OF GLASGOW2
UNIVERSITY OF NEWCASTLE UPON TYNE2
UNIVERSITY OF OSLO2
A L HOOGESTEGER FRESH SPECIALIST B V1
AALBORG HOSPITAL1
AALBORG SYGEHUS1
AARHUS UNIVERSITETSHOSPITAL SKEJBY1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACTELION PHARMACEUTICALS1
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
AGRICULTURAL INSTITUTE OF SLOVENIA1
AGRICULTURAL UNIVERSITY OF ATHENS1
AGROCOM POLSKA OPROGRAMOWANIE I NOWE MOZLIWOSCI DLA ROLNICTWA1
ANDERMATT BIOCONTROL1
ANTI CANCER COUNCIL OF VICTORIA1
APREA AB1
ARISTOTLE UNIVERSITY OF THESSALONIKI1
ARTTIC1
ASPER BIOTECH1
ASSOCIATION GROUPE ESA1
ASSOCIAZIONE IBLEA PER LA RICERCA EPIDEMIOLOGICA1
ASSOCIAZIONE IBLEA PER LA RICERCA EPIDEMIOLOGICA ORGANIZZAZIONE NON LUCRATIVA DI UTILITA SOCIALE1
ASTRAZENECA UK LIMITED1
AUSTRIAN ACADEMY OF SCIENCES OESTERREICHISCHE AKADEMIE DER WISSENSCHAFTEN1
Constancy:

Total number of partners:600

Partner loyalty:
Frequent Partner: (> 2 projects): 167
Rare Partner: 433

Frequent / Rare Partner Ratio: 0.39

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES31
RTD HORIZONTAL TOPICS17
SOCIAL AND ECONOMIC CONCERNS12
PROTECTING MAN AND HIS ENVIRON3
ENERGY2
AGRICULTURE AND MARINE RESOURC2

Project overview:

Start dateProjectacronymrolefundingpartners
2016-09-01Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network SYNTRAINparticipant3.990.26910
2014-12-01Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine MEL-PLEXparticipant3.605.35710
2014-02-01Lysosomes as targets for cancer therapy LYSOSOMEparticipant2.499.9601
2013-11-01Comparing health services interventions for the prevention of HPV-related cancer COHEAHRparticipant5.991.52812
2013-11-01"PanCare Studies in Fertility and Ototoxicity to Improve Quality of Life after Cancer during Childhood, Adolescence and Young Adulthood" PANCARELIFEparticipant5.998.27916
2012-04-01Exploring ’synthetic lethality’ and ’synthetic viability’ to elucidate responses of breast and prostate cancer cells to DNA damage and treatment resistance SYNviacoordinator238.0691
2012-03-01Health consequences of noise exposure from road traffic QUIETparticipant1.334.8902
2011-02-01The DNA damage response and breast cancer DDRESPONSEparticipant6.000.0006
2011-02-01Epidemiological study to quantify risks for paediatric computerized tomography and to optimise doses EPI-CTparticipant2.998.59419
2011-01-01INTEGRATING ARMENIA INTO ERA INARMERAparticipant499.7103
2011-01-01A European Platform for Translational Cancer Research EUROCANPLATFORMparticipant11.998.45428
2010-03-01Epidemiological Studies of Exposed Southern Urals Populations SOLOparticipant4.997.52012
2010-02-01Consortium on Health and Ageing: Network of Cohorts in Europe and the United States CHANCESparticipant11.932.39817
2009-05-01Collaborative oncological gene-environment study COGSparticipant11.715.50116
2009-04-01Europe against cancer: optimisation of the use of registries for scientific excellence in research EUROCOURSEparticipant1.999.40815
2008-09-01Prospective cohort studies of children with substantial medical diagnostic exposure CHILD-MED-RADparticipant279.9319
2008-06-01European study of cohorts for air pollution effects ESCAPEparticipant5.858.97326
2008-04-01An integrated concept of tumour metastasis: implications for therapy TUMICparticipant2.999.76814
2008-02-01Apoptosis systems biology applied to cancer and AIDS. An integrated approach of experimental biology, data mining, mathematical modelling, biostatistics, systems engineering and molecular medicine APO-SYSparticipant11.000.00024
2008-01-01Genomic instability in cancer and precancer GENICAparticipant2.994.97911
2006-10-01An examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes INTERACTparticipant10.000.00032
2006-01-01Increasing Fruit consumption through a trans disciplinary approach leading to High quality produce from environmentally safe, sustainable methods. ISAFRUITparticipant13.790.60263
2006-01-01The role of chronic INfections in the development of CAncer INCAparticipant12.400.00028
2005-12-01European Prospective Investigation into Cancer, Chronic Diseases, Nutrition and Lifestyle EPICparticipant999.74527
2005-10-01Feasibility Study for Coordination of National Cancer Research Activities EUROCAN+PLUSparticipant3.000.00017
2005-05-01DNA damage response and repair mechanisms DNA REPAIRparticipant11.500.00015
2005-04-01The impact of key determinants on the current and future burden of cancer in Europe EUROCADETparticipant987.96312
2005-01-01Diet, obesity and genes DIOGENESparticipant14.515.86537
2004-12-01Manipulating tumour suppression: a key to improve cancer treatment ACTIVEP53participant6.000.00026
2004-07-01Identification of molecular pathways that regulate the organ-specific metastasis of breast cancer BRECOSMparticipant3.430.27315
2004-02-01Mutant p53 as target for improved cancer treatment MUTP53participant8.000.00016
2003-12-01The role of protein phosphorylation in biological response to genotoxie stress CHECKPOINTcoordinator109.6251
2002-10-01Outcome and impact of specific treatment in european research on melanoma (OISTER) OISTERparticipant1.636.3007
2002-05-01The role of Hsp70 stress protein-based protective machinery in cancer cells coordinator90.0006
2002-03-01Cervical cancer public education programme (CCPED) CCPEDparticipant356.66512
2001-11-01European searchable tumour cell line database (ESTDAB) ESTDABparticipant1.678.8677
2001-10-01Molecular mechanisms of senescence and ageing (CELLAGE) CELLAGEparticipant2.196.1438
2001-09-01Deregulation of cell cycle progression in human tumorigenesis (E2F AND MYC) E2F AND MYCparticipant1.102.1385
2001-01-01Development of mathematical models of novel hpv-based cervical cancer screening protocols for evaluation of the projected health and cost benefits HPVCCSparticipant1.278.5588
2000-10-01Exploiting the hsp70 chaperone machine for novel therapeutic strategies in human diseases and for the engineering of productive cellular biomolecular factories THE HSP70 CHAPERONEparticipant1.573.9117
2000-03-01Radiation induced cell cycle checkpont control and cancer coordinator143.8021
2000-02-01Immunology and ageing in Europe participant945.00029
2000-02-01International case control studies of cancer in relation to mobile telephone use INTERPHONEparticipant3.850.03512

Alias institution names:
  • DANISH CANCER SOCIETY
  • DANISH CANCER SOCIETY INSTITUTE OF CANCER BIOLOGY
  • DANISH CANCER SOCIETY INSTITUTE OF CANCER EPIDEMIOLOGY
  • KRAEFTENS BEKAEMPELSE
  • KRAEFTENS BEKAEMPELSE DANISH CANCER SOCIETY

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum
Ads: